Clinical trial
Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability
NCT07239414 is registered in ClinicalTrials.gov with Sohaib Ashraf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability
- Lead sponsor
- Sohaib Ashraf
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 10, 2025
- Completion date
- February 21, 2027
- Enrollment
- 690 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular